Research Focus

Research and Technology Management; NE Auditor

Recent additions – View all

1. Assessment of the efficacy of therapies following venetoclax discontinuation in CLL reveals BTK inhibition as an effective strategy

   Journal Article

   Mato, A. R.; Roeker, L. E.; Jacobs, R.; Hill, B. T.; Lamanna, N.; Brander, D.; Shadman, M.; Ujjani, C. S.; Yazdy, M. S.; Perini, G. F.; more...
   Clinical Cancer Research (2020)

   Fulltext@MSK | Save
2. Efficacy of therapies following venetoclax discontinuation in CLL: Focus on B-cell receptor signal transduction inhibitors and cellular therapies

   Meeting Abstract

   Mato, A. R.; Roeker, L. E.; Eyre, T. A.; Jacobs, R.; Hill, B. T.; Lamanna, N.; Brander, D. M.; Shadman, M.; Ujjani, C.; Yazdy, M.; more...
   Blood (2019)

   Fulltext@MSK | Save